Abeer M Shaaban Selected Research

Male Breast Neoplasms (Male Breast Cancer)

1/2022	Morphological Features and Immunohistochemical Profiling of Male Breast Gynaecomastia; A Large Tissue Microarray Study.
10/2018	Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
5/2017	A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer.
1/2017	Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.
10/2016	HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
11/2014	Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
6/2012	A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abeer M Shaaban Research Topics

Disease

30	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2002
18	Neoplasms (Cancer) 01/2022 - 12/2003
7	Male Breast Neoplasms (Male Breast Cancer) 01/2022 - 06/2012
4	Carcinoma (Carcinomatosis) 05/2022 - 01/2018
4	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2022 - 12/2003
3	Carcinogenesis 08/2010 - 12/2003
3	Hyperplasia 12/2005 - 02/2002
2	Rare Diseases (Rare Disease) 08/2017 - 11/2014
2	Ductal Carcinoma 07/2016 - 06/2010
2	Residual Neoplasm 01/2016 - 09/2015
1	Papillary Carcinoma 01/2022
1	Margins of Excision 01/2021
1	Calciphylaxis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Obesity 10/2016
1	Cicatrix (Scar) 12/2013
1	Polyps 08/2013
1	Neoplasm Metastasis (Metastasis) 08/2008
1	Metaplasia 02/2004
1	Endometriosis 02/2004
1	Adenocarcinoma 02/2004

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2010
9	Hormones (Hormone)IBA 01/2022 - 02/2002
6	Estrogen Receptor alphaIBA 10/2011 - 02/2002
6	Estrogen Receptor betaIBA 09/2010 - 12/2003
5	Estrogen ReceptorsIBA 11/2014 - 12/2003
5	Protein Isoforms (Isoforms)IBA 06/2012 - 08/2008
4	Tamoxifen FDA LinkGeneric 01/2020 - 01/2008
4	Progesterone Receptors (Progesterone Receptor)IBA 09/2015 - 08/2008
4	Proteins (Proteins, Gene)FDA Link 06/2011 - 12/2003
3	Biological ProductsIBA 01/2022 - 06/2012
3	Indicators and Reagents (Reagents)IBA 01/2015 - 08/2008
3	Androgen Receptors (Androgen Receptor)IBA 11/2014 - 08/2008
2	Phenobarbital (Luminal)FDA Link 05/2022 - 06/2012
2	Keratins (Keratin)IBA 01/2022 - 01/2018
2	human ERBB2 proteinIBA 01/2016 - 09/2015
2	Monoclonal AntibodiesIBA 02/2004 - 12/2003
1	cyclo(Arg-Pro) (CI 4)IBA 02/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Lapatinib (GW572016)FDA Link 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	CalciumIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	15-hydroxyprostaglandin dehydrogenaseIBA 01/2020
1	teleocalcinIBA 10/2018
1	Small Untranslated RNAIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Histones (Histone)IBA 12/2017
1	Eukaryotic Initiation Factor-4EIBA 05/2017
1	Everolimus FDA Link 05/2017
1	Cyproterone AcetateIBA 11/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2014
1	Androgen Antagonists (Antiandrogens)IBA 11/2014
1	3-N-(2-fluoroethyl)spiperone (FESP)IBA 08/2013
1	Serine (L-Serine)FDA Link 09/2010
1	5' Untranslated Regions (5' UTR)IBA 08/2010
1	RNA (Ribonucleic Acid)IBA 08/2010
1	Messenger RNA (mRNA)IBA 06/2010
1	AntibodiesIBA 08/2008
1	Cell Adhesion MoleculesIBA 01/2008
1	Carcinoembryonic AntigenIBA 01/2008
1	AntigensIBA 02/2004
1	Cyclin AIBA 02/2004
1	Cyclin BIBA 02/2004
1	Cyclin EIBA 02/2004
1	CyclinsIBA 02/2004
1	ParaffinIBA 02/2004

Therapy/Procedure

11	Therapeutics 01/2022 - 02/2002
9	Neoadjuvant Therapy 01/2022 - 09/2015
2	Mastectomy (Mammectomy) 01/2021 - 12/2013
2	Radiotherapy 01/2021 - 01/2020
2	Lasers (Laser) 01/2020 - 01/2009
2	Drug Therapy (Chemotherapy) 01/2020 - 09/2015
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Renal Dialysis (Hemodialysis) 01/2020